Latest Biotech Startup Funding Rounds
Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.
- Rounds
- 477 Jan 1 – Oct 25, 2026
- Disclosed funding
- $20.2B 403 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
 ALORACompany profile Agricultural biotechnology company developing gene-edited crop traits to improve yield under heat and salinity stress. Agricultural biotechnology company developing gene-edited crop traits to improve yield under heat and salinity stress. | Undisclosed | Undisclosed | Biotech, Agritech | United Kingdom | Investors | |
| b Develops an AI-powered bioproduction platform for industrial ingredients | €7M | Seed | Biotech | France | Investors | |
| A AntiverseCompany profile Antiverse designs therapeutic antibodies for difficult drug targets using generative AI, engineered cell lines and in-house laboratory testing. Antiverse designs therapeutic antibodies for difficult drug targets using generative AI, engineered cell lines and in-house laboratory testing. | $9.3M | Series A | Biotech, Healthtech | United Kingdom | Investors | |
| B Develops AI platform for targeted crop protection solutions | $3.8M | Seed | Biotech, Agritech | United Kingdom | Investors | |
| OB Develops AI-driven models to decode human microbiology | $3.5M | Pre-SeedPre-seed | Biotech | United Kingdom | Investors | |
| B BreezeBioCompany profile Develops genetic medicines enabled by precise, non-viral nanoparticle delivery across tissues Develops genetic medicines enabled by precise, non-viral nanoparticle delivery across tissues | $60M | Series B | Biotech | United States | Investors | |
| T TurbineCompany profile Virtualizes biological experiments with AI to accelerate drug discovery and clinical translation Virtualizes biological experiments with AI to accelerate drug discovery and clinical translation | $25M | Series B | Biotech | Hungary | Investors | |
| SM Slate MedicinesCompany profile Advancing next-generation therapeutics for migraine and other headache disorders Advancing next-generation therapeutics for migraine and other headache disorders | $130M | Series A | Biotech | United States | Investors | |
| V VerleyCompany profile Develops functional whey protein ingredients through precision fermentation for food and nutrition manufacturers Develops functional whey protein ingredients through precision fermentation for food and nutrition manufacturers | €32M | Series A | Biotech, Foodtech | France | Investors | |
| CT Centauri TherapeuticsCompany profile Develops immunotherapeutic treatments for antimicrobial infections Develops immunotherapeutic treatments for antimicrobial infections | £6M | Series A+Series A | Biotech | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
23rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.